The Latest & Greatest News Stories


Show All

Harvoni Launch Outpacing Sovaldi

Despite a higher price point and aggressive access controls, Gilead’s second entry into the Hepatitis C market has been exceeding the highly successful launch trends of their prior entry. According…

Read more

Maximize Your Resources at Launch

Click here to read the full story published in PM360’s December 2014 issue. Gone are the days when sheer volume – €”feet on the street – €”was enough to ensure the success…

Read more

Symphony Health – A PRA Health Sciences Company

  • This field is for validation purposes and should be left unchanged.